INTERNATIONAL JOURNAL OF SCIENTIFIC DEVELOPMENT AND RESEARCH International Peer Reviewed & Refereed Journals, Open Access Journal ISSN Approved Journal No: 2455-2631 | Impact factor: 8.15 | ESTD Year: 2016
open access , Peer-reviewed, and Refereed Journals, Impact factor 8.15
Infection by the SARS-CoV-2 virus, known as COVID-19 (Corona Virus Disease-19), emerged in December 2019 in China and spread rapidly all around the world infecting many peopleand has subsequently spread rapidly throughout the world, however, well-designed studies on asymptomatic or mild, or pediatric cases of COVID-19 are scarce and desperately needed to meet the clinical need. However, a trend could be observed based on current clinical evidence. Remdesivir and favipiravir may shorten the recovery time; lopinavir/ritonavir does not demonstrate treatment efficacy in severe patients. In this review, we collected information about the most widely used drugs to treat COVID-19 (coronavirus disease 2019) belonging to groups of antivirals, antibiotics, immune modulators, and anticoagulants. Some of these compounds and drugs were used directly by inpatients, so researchers have examined others in laboratory conditions. The present study provides an update on the currently applied treatment, and intends to offer helpin relation to daily care, without seeking to replace the protocols adopted in each individual center.
"TREATMENT OF COVID-19 - A REVIEW", International Journal of Science & Engineering Development Research (www.ijsdr.org), ISSN:2455-2631, Vol.7, Issue 1, page no.224 - 230, January-2022, Available :http://www.ijsdr.org/papers/IJSDR2201032.pdf
Downloads:
000336256
Publication Details:
Published Paper ID: IJSDR2201032
Registration ID:193890
Published In: Volume 7 Issue 1, January-2022
DOI (Digital Object Identifier):
Page No: 224 - 230
Publisher: IJSDR | www.ijsdr.org
ISSN Number: 2455-2631
Facebook Twitter Instagram LinkedIn